A new research paper was published in , Volume 16, on February 28, 2025, titled "Effect of TIMPs and their minimally ...

Representatives from four leading companies highlight emerging basic and clinical research that drives renewed optimism.

Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...

Creative Bioarray Enhances Cancer Research with Innovative Drug Efficacy Testing Services NEW YORK CITY, NY, UNITED STATES, March 3, 2025 /EIN ...

Intraoperative ultra-rapid droplet digital polymerase chain reaction (UR-ddPCR) can identify tumor genetic subtype and ...

E-cigarette use, including vaping, is often seen as a safer and trendier alternative to traditional tobacco products. However ...

Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Good day, and thank you for standing by. Welcome to the Nautilus ...

EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

Successful research in targeted protein degradation depends not only on measurements at high sensitivity, speed and precision ...

A panel of 10 expert hematologists created recommendations for optimal MRD-guided ALL treatment, which were recently ...

Updated data show AYVAKIT® (avapritinib) was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life benefit and no new safety signals with multiple years of ...